Novo Nordisk Aktie
64,84
EUR
-2,13
EUR
-3,18
%
65,08
EUR
-1,70
EUR
-2,55
%
Werbung
Novo Nordisk Aktie Analyse
09:46 | Novo Nordisk Buy | UBS AG | |
16.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
13.06.25 | Novo Nordisk Buy | UBS AG | |
09.06.25 | Novo Nordisk Buy | UBS AG | |
06.06.25 | Novo Nordisk Buy | UBS AG | |
06.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
02.06.25 | Novo Nordisk Buy | UBS AG | |
02.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
Werbung
|
|||
27.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
19.05.25 | Novo Nordisk Buy | UBS AG | |
19.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
16.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.05.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
09.05.25 | Novo Nordisk Buy | UBS AG | |
08.05.25 | Novo Nordisk Buy | Deutsche Bank AG | |
08.05.25 | Novo Nordisk Buy | UBS AG | |
07.05.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
02.05.25 | Novo Nordisk Buy | UBS AG | |
02.05.25 | Novo Nordisk Buy | UBS AG | |
30.04.25 | Novo Nordisk Buy | UBS AG | |
30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
28.04.25 | Novo Nordisk Buy | UBS AG | |
22.04.25 | Novo Nordisk Buy | UBS AG | |
22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
17.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
08.04.25 | Novo Nordisk Buy | UBS AG | |
07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
07.04.25 | Novo Nordisk Buy | UBS AG | |
04.04.25 | Novo Nordisk Buy | UBS AG | |
03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
31.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.03.25 | Novo Nordisk Buy | UBS AG | |
24.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
21.03.25 | Novo Nordisk Buy | UBS AG | |
17.03.25 | Novo Nordisk Buy | UBS AG | |
14.03.25 | Novo Nordisk Buy | UBS AG | |
11.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
11.03.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
10.03.25 | Novo Nordisk Buy | UBS AG | |
10.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
07.03.25 | Novo Nordisk Buy | UBS AG | |
04.03.25 | Novo Nordisk Buy | Deutsche Bank AG |
Werbung
Werbung